OmniReliant will use the patented product to compliment the company’s patent pending warming foam acne treatment product. Lead scientists William Bess and Leonard Mackles, who conceived the product, have agreed to sell the patent and collaborate with OmniReliant Holdings, to bring this breakthrough formula to the highly competitive acne treatment market.
Paul Morrison, CEO of OmniReliant, said: “We believe this patent enhances our portfolio by adding the knowledge of respected academics and allows OmniReliant to bring unique products to market that can make a difference.”